# Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis

> **NCT02344719** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 30 (actual)

## Conditions studied

- Cirrhosis
- Portal Hypertension

## Interventions

- **DRUG:** Taurin 6g per day per oral for 28 days
- **PROCEDURE:** HVPG Measurement baseline
- **PROCEDURE:** HVPG Measurement day 28
- **DRUG:** Placebo 6g per day per oral for 28 days

## Key facts

- **NCT ID:** NCT02344719
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2015-05
- **Final completion:** 2015-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02344719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02344719, "Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02344719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*